A PILOT TRIAL OF AC (ADRIAMYCIN, CYCLOPHOSPHAMIDE) CHEMOTHERAPY WITH G-CSF (GRANULOCYTE COLONY-STIMULATING FACTOR) FOLLOWED BY INFUSIONAL TAXOL (PACLITAXEL) AS ADJUVANT TREATMENT FOR HIGH RISK STAGE II AND STAGE III BREAST CANCER PATIENTS: